Unknown

Dataset Information

0

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.


ABSTRACT: Purpose: Although local oncolytic viral therapy (OVT) may enhance tumor lysis, antigen release, and adaptive immune responses, systemic antitumor responses post-therapy are limited. Adoptive immunotherapy with autologous dendritic cells (DC) and cytokine-induced killer cells (DC-CIK) synergizes with systemic therapies. We hypothesized that OVT with Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor (HSV-GM-CSF) would induce adaptive T cell responses that could be expanded systemically with sequential DC-CIK therapy. Patients and Methods: We performed a pilot study of intratumoral HSV-GM-CSF OVT followed by autologous DC-CIK cell therapy. In addition to safety and clinical endpoints, we monitored adaptive T cell responses by quantifying T cell receptor (TCR) populations in pre-oncolytic therapy, post-oncolytic therapy, and after DC-CIK therapy. Results: Nine patients with advanced malignancy were treated with OVT (OrienX010), of whom seven experienced stable disease (SD). Five of the OVT treated patients underwent leukapheresis, generation, and delivery of DC-CIKs, and two had SD, whereas three progressed. T cell receptor sequencing of TCR ? sequences one month after OVT therapy demonstrates a dynamic TCR repertoire in response to OVT therapy in the majority of patients with the systematic expansion of multiple T cell clone populations following DC-CIK therapy. This treatment was well tolerated and long-term event free and overall survival was observed in six of the nine patients. Conclusions: Strategies inducing the local activation of tumor-specific immune responses can be combined with adoptive cellular therapies to expand the adaptive T cell responses systemically and further studies are warranted.

SUBMITTER: Ren J 

PROVIDER: S-EPMC5414875 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy.

Ren Jun J   Gwin William R WR   Zhou Xinna X   Wang Xiaoli X   Huang Hongyan H   Jiang Ni N   Zhou Lei L   Agarwal Pankaj P   Hobeika Amy A   Crosby Erika E   Hartman Zachary C ZC   Morse Michael A MA   H Eng Kevin K   Lyerly H Kim HK  

Oncoimmunology 20161207 4


<i>Purpose</i>: Although local oncolytic viral therapy (OVT) may enhance tumor lysis, antigen release, and adaptive immune responses, systemic antitumor responses post-therapy are limited. Adoptive immunotherapy with autologous dendritic cells (DC) and cytokine-induced killer cells (DC-CIK) synergizes with systemic therapies. We hypothesized that OVT with Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor (HSV-GM-CSF) would induce adaptive T cell responses that could be expand  ...[more]

Similar Datasets

| S-EPMC3719441 | biostudies-literature
| S-EPMC2894410 | biostudies-literature
| S-EPMC1164429 | biostudies-literature
| S-EPMC3014056 | biostudies-literature
| S-EPMC5897440 | biostudies-literature
| S-EPMC5029719 | biostudies-literature
| S-EPMC4742622 | biostudies-literature
| S-EPMC9804750 | biostudies-literature
| S-EPMC5438114 | biostudies-literature
| S-EPMC6116484 | biostudies-literature